Strategic investments in non-communicable diseases (NCD) research in Africa: the GSK Africa NCD Open Lab

In March 2014, GSK announced a number of new strategic investments in Africa. One of these included investment of up to 25 million Pounds Sterling (£25 million) to create the world’s first R&D Open Lab to increase understanding of non-communicable diseases (NCDs) in Africa. The vision is to crea...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, Matthew D, Dufton, Ann M, Katso, Roy M, Williams, Pauline M, Gatsi, Sally A, Strange, Michael E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinics Cardive Publishing 2015
Materias:
Cardiovascular Topics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557486/
https://www.ncbi.nlm.nih.gov/pubmed/25962942
http://dx.doi.org/10.5830/CVJA-2015-042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4557486/
https://www.ncbi.nlm.nih.gov/pubmed/25962942
http://dx.doi.org/10.5830/CVJA-2015-042

Ejemplares similares